These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

878 related items for PubMed ID: 30867818

  • 1. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagy.
    Zhang X, Qi Z, Yin H, Yang G.
    Theranostics; 2019; 9(4):1096-1114. PubMed ID: 30867818
    [Abstract] [Full Text] [Related]

  • 2. Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization.
    Fischer C, Leithner K, Wohlkoenig C, Quehenberger F, Bertsch A, Olschewski A, Olschewski H, Hrzenjak A.
    Mol Cancer; 2015 Jan 21; 14():4. PubMed ID: 25608569
    [Abstract] [Full Text] [Related]

  • 3. IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells.
    Xu S, Yu C, Ma X, Li Y, Shen Y, Chen Y, Huang S, Zhang T, Deng W, Wang Y.
    Eur J Pharmacol; 2021 Mar 05; 894():173817. PubMed ID: 33345849
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
    Sun XP, Dong X, Lin L, Jiang X, Wei Z, Zhai B, Sun B, Zhang Q, Wang X, Jiang H, Krissansen GW, Qiao H, Sun X.
    FEBS J; 2014 Jan 05; 281(1):115-28. PubMed ID: 24165223
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L, Zhou Y, Li Y, Zhou J, Wu Y, Cui Y, Yang G, Hong Y.
    Cancer Lett; 2015 Feb 28; 357(2):520-6. PubMed ID: 25499080
    [Abstract] [Full Text] [Related]

  • 10. Baohuoside I inhibits resistance to cisplatin in ovarian cancer cells by suppressing autophagy via downregulating HIF-1α/ATG5 axis.
    Zhou Y, Liu T, Wu Q, Wang H, Sun Y.
    Mol Carcinog; 2023 Oct 28; 62(10):1474-1486. PubMed ID: 37283234
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
    Lau CK, Yang ZF, Ho DW, Ng MN, Yeoh GC, Poon RT, Fan ST.
    Clin Cancer Res; 2009 May 15; 15(10):3462-71. PubMed ID: 19447872
    [Abstract] [Full Text] [Related]

  • 13. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T, Cui L, Wang H, Wang H, Han N.
    J Transl Med; 2018 Jun 14; 16(1):164. PubMed ID: 29898734
    [Abstract] [Full Text] [Related]

  • 14. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation.
    Wang H, Fang L, Jiang J, Kuang Y, Wang B, Shang X, Han P, Li Y, Liu M, Zhang Z, Li P.
    Cell Death Dis; 2018 Oct 30; 9(11):1103. PubMed ID: 30375398
    [Abstract] [Full Text] [Related]

  • 15. Effects of lentivirus-mediated HIF-1alpha knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells.
    Hao J, Song X, Song B, Liu Y, Wei L, Wang X, Yu J.
    Cancer Gene Ther; 2008 Jul 30; 15(7):449-55. PubMed ID: 18421307
    [Abstract] [Full Text] [Related]

  • 16. ATF4-mediated microRNA-145/HDAC4/p53 axis affects resistance of colorectal cancer cells to 5-fluorouracil by regulating autophagy.
    Zhao L, Chen H, Zhang Q, Ma J, Hu H, Xu L.
    Cancer Chemother Pharmacol; 2022 May 30; 89(5):595-607. PubMed ID: 35312836
    [Abstract] [Full Text] [Related]

  • 17. Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.
    Chan KK, Wong OG, Wong ES, Chan KK, Ip PP, Tse KY, Cheung AN.
    Int J Cancer; 2018 Sep 15; 143(6):1456-1469. PubMed ID: 29663364
    [Abstract] [Full Text] [Related]

  • 18. Nucleus accumbens-associated protein-1 promotes glycolysis and survival of hypoxic tumor cells via the HDAC4-HIF-1α axis.
    Zhang Y, Ren YJ, Guo LC, Ji C, Hu J, Zhang HH, Xu QH, Zhu WD, Ming ZJ, Yuan YS, Ren X, Song J, Yang JM.
    Oncogene; 2017 Jul 20; 36(29):4171-4181. PubMed ID: 28319066
    [Abstract] [Full Text] [Related]

  • 19. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
    Zhang XY, Zhang M, Cong Q, Zhang MX, Zhang MY, Lu YY, Xu CJ.
    Int J Biochem Cell Biol; 2018 Feb 20; 95():9-16. PubMed ID: 29247711
    [Abstract] [Full Text] [Related]

  • 20. Scutellaria baicalensis targets the hypoxia-inducible factor-1α and enhances cisplatin efficacy in ovarian cancer.
    Hussain I, Waheed S, Ahmad KA, Pirog JE, Syed V.
    J Cell Biochem; 2018 Sep 20; 119(9):7515-7524. PubMed ID: 29797601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.